Vaccinex VCNX
OTC VCNX
$0.70 +0.04 (+6.06%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vaccinex, Inc. (VCNX) Cost of Revenue (2018 - 2020)

Updated

Vaccinex's Cost of Revenue came in at $2,000 for FY2020, down 99.0% from $199,000 in FY2019.

Analysis

Vaccinex, Inc. (VCNX) Cost of Revenue (2018 - 2020) Analysis & Trends

Going back to FY2017, Vaccinex's Cost of Revenue data covers 4 years.

  • Cost of Revenue carries a three-year compound annual growth rate of -76.8% (FY2017 to FY2020).
  • Per Business Quant, earlier years put Cost of Revenue at $199,000 in FY2019 (-80.7%), $1.03 million in FY2018 (+545.6%) and $160,000 in FY2017.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 2,000.00
Sep 30, 2019 8,000.00
Jun 30, 2019 16,000.00
Mar 31, 2019 175,000.00
Dec 31, 2018 301,000.00
Sep 30, 2018 246,000.00
Jun 30, 2018 246,000.00
Mar 31, 2018 240,000.00
API Access

Vaccinex, Inc. Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VCNX&period=max&api_key=YOUR_API_KEY